Rapamycin rescues learning, memory in Alzheimer’s mouse model
February 24, 2010
Rapamycin, a drug that keeps the immune system from attacking transplanted organs, may have another exciting use: fighting Alzheimer’s disease.
Scientists: Protein that predicts Alzheimer’s also predicts HIV progression
June 17, 2008
A protein that is one of the major predictors of Alzheimer’s disease also predicts the pace at which HIV-infected persons will progress to death, San Antonio scientists reported this week.
March 29 ‘Spring Fling’ dinner/dance to benefit Alzheimer’s research
March 13, 2008
A “Spring Fling” dinner and dance later this month will raise funds for Alzheimer’s disease research at the Sam and Ann Barshop Institute for Longevity and Aging Studies.
San Antonio study examines investigational drug for Alzheimer’s
June 6, 2006
San Antonio residents diagnosed with Alzheimer’s disease may be eligible to participate in a clinical study offered by the Health Science Center. The study will assess whether an investigational drug, Flurizan, can slow Alzheimer’s progression.
Screening method identifies unfolded, aberrant proteins
February 21, 2006
During normal aging and various neurodegenerative diseases such as Alzheimer’s, Lou Gehrig’s and Parkinson’s diseases, proteins become unfolded or clump together, thereby losing their function and damaging the cells and tissues.
Putting the proverbial brakes on aging
May 18, 2004
The University of Texas Health Science Center at San Antonio has received a $2.5 million grant for a National Institute on Aging (NIA) Intervention Testing Center, one of three such U.S. centers established by the NIA to test potential therapeutic interventions to slow the aging process.